Peripheral Stent Market Size, Industry Share & Trends | 2032
Peripheral Stent Market Size, Industry Share & Trends | 2032
Segments - Peripheral Stent Market by Product (Covered Stents, Bare Metal Stents (BMS), and Drug-Eluting Stents (DES)), Artery Type (Iliac Stents, Renal & Related Stents, Femoral-popliteal Stents, and Carotid Stents), End-user (Hospitals, Ambulatory Surgical Centers/Outpatients, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
Upcoming
| Report ID :HC-6493
| 4.8 Rating
| 93 Reviews
| 286 Pages
| Format :
Report Description
Peripheral Stent Market Outlook 2032
The global peripheral stent market size was USD XX Billion in 2023 and is projected to reach USD XX Billion by 2032, expanding at a CAGR of XX% during 2024–2032. The market growth is attributed to the increasing demand for the advanced heart stent solutions.
Expansion of applications beyond traditional vascular interventions of peripheral stents is boosting the market. Peripheral stents are being utilized in non-vascular applications, such as biliary and esophageal stenting, providing minimally invasive solutions for a broad range of medical conditions. Moreover, the increasing number of elderly patients suffering from cardiovascular disease creates a massive demand for stent solutions.
-
According to the report published by the WHO on October 1, 2022, the older population aged over 60 years is estimated to increase from One billion in 2020 to 1.4 billion in 2050.
Impact of Artificial Intelligence (AI) in the Peripheral Stent Market
The use of artificial intelligence is likely to boost the peripheral stent market. Artificial intelligence enhances the precision and accuracy of stent placement procedures through advanced imaging and navigational systems. Moreover, AI-driven predictive analytics tools enable healthcare providers to assess patient risk profiles leading to effective intervention.
Peripheral Stent Market Dynamics
Major Drivers
Increasing prevalence of cardiovascular diseases is expected to drive the market during the forecast period. Factors such as sedentary lifestyles and unhealthy dietary habits are increasing the cases of heart disease globally. For instance, according to the report published by the WHO on June 11, 2021, an estimated 17.9 million people died from CVDs in 2019. Moreover, the increasing awareness regarding the prevention, diagnosis, and treatment of cardiovascular diseases is boosting the market.
Existing Restraints
High costs associated with peripheral stent implantation procedures are expected to hinder the market in the coming years. The cost of the stents themselves and hospitalization expenses deter patients from seeking treatment. Furthermore, the complications associated with peripheral stent placement procedures, such as stent thrombosis, restenosis, and stent fractures further hinder the market.
Emerging Opportunities
Rising adoption of bioresorbable stents is expected to create immense opportunities for the players competing in the market during the projected period. Manufacturers are focusing on development of bioresorbable stents designed to gradually dissolve and be absorbed by the body. This eliminates the need for permanent implantation and potentially reduces the risk of long-term complications, such as restenosis and thrombosis. Moreover, the increasing focus on minimally invasive peripheral arterial disease (PAD) treatments is fueling the demand for innovative stent technologies.
Scope of the Peripheral Stent Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
|
Attributes |
Details |
|
Report Title |
Peripheral Stent Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017 -2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Product (Covered Stents, Bare Metal Stents (BMS), and Drug-Eluting Stents (DES)), Artery Type (Iliac Stents, Renal & Related Stents, Femoral-popliteal Stents, and Carotid Stents), and End-user (Hospitals, Ambulatory Surgical Centers/Outpatients, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott; Alvimedica; B. Braun Medical Inc.; Biosensors International Group, Ltd; BIOTRONIK SE & Co. KG; Boston Scientific Corporation; Cook Group; Medtronic; Stentys; and Terumo Corporation. |
Regional Outlook
In terms of region, the global peripheral stent market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to the large patient pool suffering from cardiovascular diseases in the region. For instance, according to a report published by the Centers for Disease Control and Prevention on May 15, 2023, heart disease is the primary cause of death in the US, resulting in one death every 33 seconds. Moreover, the advanced healthcare infrastructure further facilitates the widespread adoption of these stents, thereby boosting the market in the region.
The market in Asia Pacific is projected to grow at a significant pace in the years to come, owing to the rapidly growing elderly population and expanding access to healthcare services across the region. Furthermore, the increasing incidence of cardiovascular diseases further boosts the demand for peripheral stents in this region.
Peripheral Stent Market Segment Insights
Product Segment Analysis
Based on product, the peripheral stent market is divided into covered stents, bare metal stents (BMS), and drug-eluting stents (DES). The drug-eluting stents segment held a major share of the market in 2023, due to its superior efficacy in preventing restenosis as compared to other types of stents.
DES are coated with medication that help in reducing the risk of re-narrowing after the stent placement procedure. Moreover, increasing patients with high risk of restenosis further boosts the demand for DES in the coming years.
The covered stents segment is expected to expand at a significant growth rate in the coming years, owing to their growing demand in minimally invasive endovascular procedures for the treatment of vascular conditions. Furthermore, the technological advancements to improve the durability and flexibility of covered stents further fuel the segment.
Artery Type Segment Analysis
On the basis of artery type, the global market is segregated into iliac stents, renal & related stents, femoral-popliteal stents, and carotid stents. The femoral-popliteal segment held a large market share in 2023, due to the high prevalence of peripheral artery disease (PAD) affecting the femoral-popliteal artery. Femoral-popliteal stents are specifically designed to treat lesions in these areas, which are frequently affected in patients with PAD. Moreover, the increasing awareness about PAD and its treatment options further boost the segment.
-
As per the report published by the National Library of Medicine on July 12, 2022, around 202.06 million people are suffering from PAD globally.
The iliac stents segment is anticipated to expand at a substantial CAGR during the forecast period, owing to their growing demand to restore blood flow and alleviate symptoms such as leg pain and claudication in patients with iliac artery disease. Moreover, advancements in stent design and the development of dedicated iliac stent systems are anticipated to further propel the segment.
End-user Segment Analysis
Based on end-user, the peripheral stent market is segmented into hospitals, ambulatory surgical centers/outpatients, and others. The ambulatory surgical centers/outpatients segment is projected to register a robust growth rate during the assessment years, due to the increased convenience for patients undergoing elective procedures, including peripheral stent placement. Additionally, the ongoing efforts to reduce healthcare costs and alleviate the burden on hospital resources makes ambulatory surgical centers an attractive option for stents surgeries, thus boosting the market.
Segments
The peripheral stent market has been segmented on the basis of
Product
- Covered Stents
- Bare Metal Stents (BMS)
- Drug-Eluting Stents (DES)
Artery Type
- Iliac Stents
- Renal & Related Stents
- Femoral-popliteal Stents
- Carotid Stents
End-user
- Hospitals
- Ambulatory Surgical Centers/Outpatients
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the global peripheral stent market are Abbott; Alvimedica; B. Braun Medical Inc.; Biosensors International Group, Ltd; BIOTRONIK SE & Co. KG; Boston Scientific Corporation; Cook Group; Medtronic; Stentys; and Terumo Corporation.
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instances,
-
On May 13, 2022, Medtronic, a global medical device supplier, announced that FDA has approved the Onyx Frontier, a drug-eluting coronary stent system. It is designed to provide improved accuracy in complex coronary cases, helping cardiologists.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Peripheral Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peripheral Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peripheral Stent Market - Supply Chain
4.5. Global Peripheral Stent Market Forecast
4.5.1. Peripheral Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peripheral Stent Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Peripheral Stent Market Absolute $ Opportunity
5. Global Peripheral Stent Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Peripheral Stent Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Ambulatory Surgical Centers/Outpatients
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Peripheral Stent Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Peripheral Stent Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Peripheral Stent Demand Share Forecast, 2019-2026
7. North America Peripheral Stent Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Peripheral Stent Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Peripheral Stent Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers/Outpatients
7.4.3. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Peripheral Stent Demand Share Forecast, 2019-2026
8. Latin America Peripheral Stent Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Peripheral Stent Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Peripheral Stent Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers/Outpatients
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Peripheral Stent Demand Share Forecast, 2019-2026
9. Europe Peripheral Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Peripheral Stent Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Peripheral Stent Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers/Outpatients
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Peripheral Stent Demand Share Forecast, 2019-2026
10. Asia Pacific Peripheral Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Peripheral Stent Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Peripheral Stent Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers/Outpatients
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Peripheral Stent Demand Share Forecast, 2019-2026
11. Middle East & Africa Peripheral Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Peripheral Stent Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Peripheral Stent Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers/Outpatients
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Peripheral Stent Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Peripheral Stent Market: Market Share Analysis
12.2. Peripheral Stent Distributors and Customers
12.3. Peripheral Stent Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott
12.4.2. Alvimedica
12.4.3. B. Braun Medical Inc.
12.4.4. Biosensors International Group, Ltd
12.4.5. BIOTRONIK SE & Co. KG
12.4.6. Boston Scientific Corporation
12.4.7. Cook Group
12.4.8. Medtronic
12.4.9. Stentys
12.4.10. Terumo Corporation
Methodology
Related Reports
Some other reports from this category!
Our Clients
